155 related articles for article (PubMed ID: 2189070)
1. Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia.
Niederwieser DW; Appelbaum FR; Gastl G; Gersdorf E; Meister B; Geissler D; Tratkiewicz JA; Thaler J; Huber C
N Engl J Med; 1990 Jun; 322(25):1794-6. PubMed ID: 2189070
[No Abstract] [Full Text] [Related]
2. Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation.
De Witte T; Vreugdenhil G; Schattenberg A
Transplant Proc; 1993 Aug; 25(4 Suppl 3):57-60. PubMed ID: 8351721
[No Abstract] [Full Text] [Related]
3. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
Giralt S; Escudier S; Kantarjian H; Deisseroth A; Freireich EJ; Andersson BS; O'Brien S; Andreeff M; Fisher H; Cork A
N Engl J Med; 1993 Sep; 329(11):757-61. PubMed ID: 7688862
[TBL] [Abstract][Full Text] [Related]
4. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
[TBL] [Abstract][Full Text] [Related]
5. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation. The state of the art.
Thomas ED
Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
[No Abstract] [Full Text] [Related]
7. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
Huang H; Lin M; Meng H
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
9. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
Mendeleeva LP
Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
[No Abstract] [Full Text] [Related]
10. Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation.
Kumar A; Styler MJ; Topolsky DL; Crilley PA; Przybysz TM; Gladstone DE
Am J Hematol; 2002 Nov; 71(3):227-8. PubMed ID: 12410583
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation at The Mount Sinai Hospital.
Fruchtman SM; Scigliano E; Ross V; Abramowitz A; Lipton J; Mandell L; Shank B
Mt Sinai J Med; 1994 Jan; 61(1):3-12. PubMed ID: 8183289
[No Abstract] [Full Text] [Related]
12. Graft-versus-leukemia reactions following bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S
Prog Clin Biol Res; 1992; 377():113-25; discussion 126-7. PubMed ID: 1438407
[No Abstract] [Full Text] [Related]
13. Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia.
Pieroni F; Oliveira FM; Panepucci RA; Voltarelli JC; Simões BP; Falcão RP
Bone Marrow Transplant; 2006 Apr; 37(8):801-2. PubMed ID: 16501585
[No Abstract] [Full Text] [Related]
14. [Granulocyte colony stimulating factor for bone marrow transplantation].
Masaoka T
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3543-9. PubMed ID: 2479338
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for chronic myeloid leukaemia.
Goldman JM
Bone Marrow Transplant; 1991; 7 Suppl 2():62-3. PubMed ID: 1878724
[No Abstract] [Full Text] [Related]
16. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of flow karyotyping in myelocytic leukemia by stimulation of different subpopulations of cells in blood or bone marrow samples.
Arkesteijn GJ; van Dekken H; Martens AC; Hagenbeek A
Cytometry; 1990; 11(1):196-201. PubMed ID: 2307058
[TBL] [Abstract][Full Text] [Related]
18. Preliminary experience with allogeneic bone marrow transplantation in haematological disorders in India.
Saikia TK; Advani SH; Gopal R; Nair CN; Dinsha KA; Kurkure PA; Swaroop VS; Jagannath P; Sharma S; Rao RS
J Assoc Physicians India; 1990 May; 38(5):332-4. PubMed ID: 2387813
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
20. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
